보고서 요약(국문)

개요
글로벌 유전자 예측 도구 시장은 2022년 YY억 달러에 달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY억 달러에 이를 것으로 예상됩니다.
글로벌 유전자 예측 도구 시장은 여러 요인의 영향으로 지난 몇 년간 상당한 성장과 변화를 경험해 왔습니다. 기본적으로 유전자 예측은 게놈 상에서 유전자를 식별하는 것을 의미합니다. 유전자를 암호화하는 게놈 DNA 영역을 찾는 과정을 유전자 발견이라고도 합니다. 단백질, RNA 및 조절 유전자와 같은 기타 기능적 구성 요소를 암호화하는 유전자가 여기에 포함됩니다.
특히 개발도상국의 정부 투자 및 연구는 첨단 소프트웨어 또는 서비스 활용을 지속적으로 촉진하고 글로벌 유전자 예측 도구 시장을 활성화할 것입니다. 관련 혁신 제품에는 신약 개발을 위한 JIGSAW, GENEID와 같은 새로운 도구의 사용이 포함됩니다.

시장 동향: 성장 동인 및 제약 요인
협력 및 이니셔티브 증가
선진국들은 높은 투자, 소득 수준 및 인프라 개발에 힘입어 의료 부문이 빠르게 발전하고 있습니다. 여러 국가에서 연구 활동 증가로 인해 유전자 예측 도구에 대한 수요가 크게 증가했습니다. 각국에서 기술 발전을 기반으로 한 다양한 제품 출시가 시장 성장을 견인하는 중요한 요인이 될 것입니다.
2022년 1월 18일, Thermo Fisher Scientific과 Oncocyte Corporation은 Ion Torrent Genexus 시스템을 활용한 체외 진단(IVD) 검사 공동 개발 및 마케팅 계약을 체결했습니다. 정밀 진단 기업인 Oncocyte Corporation은 암의 진단, 관리 및 모니터링에 있어 중요한 의사 결정을 내리는 데 도움이 되는 명확한 정보를 제공함으로써 환자 치료 결과를 개선하고 있습니다.

또한, 2023년 7월 20일, 서열 특이적 DNA 인식을 위한 아연 손가락 단백질(ZFP)을 이용한 후성유전학적 약물 개발을 위해 임상 단계의 유전체 의학 회사인 상가모 테라퓨틱스(Sangamo Therapeutics, Inc.)와 단일 용량 후성유전학적 편집 치료법을 개발한 유전체 의학 회사인 크로마 메디신(Chroma Medicine, Inc.)이 연구 평가, 옵션 및 라이선스 계약을 체결했습니다.
더불어, 여러 질병 관리를 위한 신기술 및 소프트웨어의 활용 증가, 사람들의 인식 제고, 혁신적인 진단 또는 치료 제품 개발을 위한 연구 증가는 유전자 예측 도구 시장 성장을 이끄는 주요 요인이 될 것입니다.
유전자 예측 도구와 관련된 한계
최근 연구에 따르면 단백질 코딩 유전자는 자동화된 게놈 주석 방법으로 적절하게 식별하기 어려운 것으로 나타났습니다. 상당한 유전 서열 다양성, 진핵생물 엑손 매핑의 복잡성, 게놈 어셈블리 초안의 상태, 또는 고전적인 유전적 특성과의 변이 등이 이러한 실패의 원인이 될 수 있습니다.

따라서 현재 사용 중인 다양한 유전자 예측 알고리즘을 비교하여 신뢰성을 평가하고, 가장 유망한 전략을 파악하며, 단백질 데이터베이스의 오류 확산을 막는 것이 중요합니다.
이 보고서에 대한 자세한 내용은 샘플을 요청하십시오.
세그먼트 분석
글로벌 유전자 예측 도구 시장은 구성 요소, 방법, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
Ab-Initio 예측 부문은 시장 점유율의 약 59%를 차지했습니다.
관련 또는 상동 단백질의 실험적으로 규명된 구조가 없는 경우, 단백질 구조의 ab initio 예측이라는 기술을 사용하여 단백질의 3차 구조를 확인할 수 있습니다. 이 접근 방식은 에너지 함수의 영향을 받는 단백질 구조를 생성합니다. 템플릿을 사용하지 않고 서열 데이터만으로 단백질 구조를 예측하는 어려운 작업을 ab initio 예측이라고 합니다.

단백질 구조 탐색은 종종 두 가지 독립적인 하위 문제로 나뉩니다. 하나는 구조 공간을 탐색하는 방법이고, 다른 하나는 정상 구조 또는 정상 구조와 유사한 구조를 비정상 구조와 구별할 수 있는 점수 시스템입니다. 항상 정상 구조로 탐색 방향을 제시할 수 있는 신뢰할 수 있는 점수 시스템은 아직 존재하지 않으며, 정상 구조에 가까운 구조를 상당수 확보할 수 있는 보편적인 탐색 전략도 없습니다. 경로 모델은 이러한 탐색과 점수 기능을 통합합니다.
2021년 생물정보학 브리핑(Briefings in Bioinformatics)에 따르면, TSSFinder라는 프로그램이 진핵생물 종의 프로모터 서열을 분석하는 데 사용되었습니다. TSSFinder는 선형 연쇄 조건부 랜덤 필드(LCCRF) 기반의 확률 모델을 사용하는 초기 전사 시작 부위(TSS) 예측 접근법으로, 문헌에 처음 공개되었습니다. TSSFinder는 새로운 생물체에 맞게 조정할 수 있으며, 기존 도구보다 정확도가 높습니다.

지리적 시장 침투
북미는 2022년 시장 점유율의 약 37%를 차지했습니다.
의료 분야에서 유전자 예측 도구에 대한 수요가 증가함에 따라 북미 제조업체들은 사업 확장의 기회를 얻고 있습니다. 북미에는 많은 생산자와 공급업체가 있으며, 이 지역의 빠른 경제 성장으로 산업 생산이 확대되어 유전자 예측 도구에 대한 수요를 견인하고 있습니다.
의료비 지출 증가, 연구 활동 확대, 기술 발전 및 다양한 연구 도구의 개발, 그리고 이 지역 전반에 걸친 바이오제약 또는 생물정보학 기업의 설립 증가는 이 지역의 유전자 예측 도구 시장 점유율 성장에 기여하고 있습니다. 사람들이 다양한 혁신적인 도구에 대한 인식을 높여감에 따라 이 분야의 시장은 성장하고 있습니다. 앞서 언급한 요소들은 북미가 세계 시장에서 주도적인 위치를 차지하고 있음을 더욱 뒷받침합니다.
북미는 미국을 중심으로 글로벌 유전자 예측 도구 시장에서 핵심적인 역할을 계속 수행하고 있습니다. 정부의 인프라 개발 및 투자 촉진 정책과 첨단 기술 발전에 대한 관심은 미국 내 유전자 예측 도구 수요를 견인했습니다. 미국은 여러 연구 및 정책을 적극적으로 추진하여 유전자 예측 도구 수요를 촉진해 왔습니다.
COVID-19 영향 분석
2019년 말 발생한 COVID-19 팬데믹은 전 세계 산업, 특히 글로벌 유전자 예측 도구 시장에 전례 없는 어려움을 초래했습니다. 각국이 봉쇄, 공급망 차질, 경제 활동 위축에 직면하면서 다양한 기기 설계를 주요 소비처로 하는 제약 부문은 큰 타격을 입었습니다. 2020년 초부터 시작된 팬데믹의 광범위한 봉쇄와 제한 조치는 전 세계적으로 여러 사업에 영향을 미쳤습니다.
주요 의료 및 생명공학 산업은 COVID-19 관리에 집중하면서 생산이 중단되었고, 이로 인해 유전자 예측 도구 수요가 급감했습니다. 그러나 현재 여러 연구가 재개되었고, 기업들은 제품 효능 검증을 위한 시험을 다시 시작했습니다. 전반적으로, 팬데믹이 전 세계 유전자 예측 도구 시장에 미치는 영향은 비교적 완만할 것으로 예상되며, ab-initio 예측 도구와 같은 혁신적인 도구에 대한 지속적인 수요와 연구로 인해 시장은 꾸준히 성장할 것으로 전망됩니다.
주요 개발 사항
• 2023년 6월 1일, DNA 시퀀싱 및 어레이 기반 기술 분야의 혁신 기업인 일루미나(Illumina Inc.)가 개발한 새로운 인공지능(AI) 알고리즘인 PrimateAI-3D가 환자의 질병 유발 유전 변이를 전례 없는 정확도로 예측합니다. 이 알고리즘의 개발 과정과 영국 바이오뱅크(UK Biobank) 코호트의 5만 개 게놈에 대한 적용 결과를 담은 두 편의 논문이 6월 2일(6648호) Science지에 게재되었습니다.

• 2023년 1월 23일, QIAGEN의 생물정보학 부서인 QIAGEN Digital Insights는 전장 엑솜 시퀀싱(WES), 전장 게놈 시퀀싱(WGS) 및 대규모 패널 시퀀싱 데이터의 평가 및 이해를 위한 획기적인 분석 속도를 통합하여 차세대 시퀀싱(NGS) 데이터 분석의 장벽을 제거하는 QIAGEN CLC Genomics Workbench Premium을 개선했습니다.
• 2022년 5월 16일, Geneious Biologics는 특정 항체의 주석, 특성 분석 및 시각화를 위한 무료 프로그램을 제공할 예정입니다. 연구자들은 온라인에서 무료로 제공되는 항체 서열 분석 도구를 통해 Geneious Biologics의 항체 주석 기능의 강력함을 직접 경험할 수 있습니다.

경쟁 환경
주요 글로벌 시장 참여 기업으로는 Thermo Fisher Scientific Inc., Softberry, Inc., Illumina, Inc., QIAGEN, GenScript, DNASTAR, BGI, Geneious, Sangamo Therapeutics, Takara Bio Inc. 등이 있습니다.
보고서 구매 이유

• 구성 요소, 방법, 응용 분야, 최종 사용자 및 지역별 글로벌 유전자 예측 도구 시장 세분화를 시각화하고 주요 기업 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 모색합니다.

• 모든 세그먼트를 포함한 유전자 예측 도구 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 기업의 핵심 제품을 모두 포함한 제품 맵핑 자료를 Excel 파일로 제공합니다.

글로벌 유전자 예측 도구 시장 보고서는 약 69개의 표, 66개의 그림, 186페이지 분량입니다.

2023년 목표 고객층
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global gene prediction tool market reached US$ YY billion in 2022 and is expected to reach US$ YY billion by 2030, growing with a CAGR of YY% during the forecast period 2023-2030.
The global gene prediction tool market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics. Basically, gene prediction involves identifying genes along the genome. The process of locating the areas of genomic DNA which encode genes is sometimes referred to as gene discovery. Genes that code for proteins, RNA, and other functional components like regulatory genes are included in this.
Government investments and research, particularly in developing economies, will continue to drive utilization of advanced software or services and boost the global gene prediction tool market. The respective innovative products includes the use of novel tools such as JIGSAW, GENEID for drug discovery.
Market Dynamics: Drivers & Restraints
Growing collaborations and initiatives
Developed economies have been witnessing rapid growth in betterment of their healthcare sectors, driven by high investments, income levels, and infrastructure development. Several countries have experienced substantial demand for gene prediction tool owing to the rising research. Various product launches with technological advanecments among different countries will be a crucial factor driving the growth of the market.
On January 18, 2022, Thermo Fisher Scientific and Oncocyte Corporation have entered into a development and collaborative marketing arrangement for a pair distributed in vitro diagnostic (IVD) assessments on the Ion Torrent Genexus System. A precision diagnostics company, Oncocyte Corporation, improving patient outcomes by delivering clear insights that inform crucial decisions in the detection, management, and monitoring of cancer.
Additionally, on July 20, 2023, in order to develop epigenetic drugs using zinc finger proteins (ZFPs) for DNA recognition which is sequence-specific, a clinical-stage genomic medicine company, Sangamo Therapeutics, Inc., and Chroma Medicine, Inc., a genomic medicine company that invented single-dose epigenetic editing treatments, have entered into a research assessment, option, and license agreement.
Furthermore, the rising utilization of novel technology and software for the management of several diseases. Rising awareness among people and increasing research for innovative diagnostic or treatment product development will be a major factor driving the growth of the gene prediction tools market.
Limitations associated with the gene prediction tools
Recent reviews have brought attention to the fact that protein-coding genes are still difficult for automated genome annotation methods to appropriately identify. Significant amounts of genetic sequence divergence, the intricacy of eukaryotic exon mapping, the state of the draft genome assemblies, or variations from classical genetic traits could all be factors in this failure.
Therefore, it is crucial to compare the many gene prediction algorithms now in use in order to gauge their dependability, pinpoint the most promising tactics, as well as to stop the propagation of mistakes in protein databases.
For more details on this report - Request for Sample
Segment Analysis
The global gene prediction tool market is segmented based on component, method, application, end user and region.
Ab-Initio Prediction segment accounted for approximately 59% of market share
In the absence of an experimentally solved structure for a related or homologous protein, a technique known as ab initio prediction of protein structures can be used to ascertain the tertiary structure of a protein. This approach creates protein structure that is influenced by energy function. The difficult endeavor of predicting protein structures solely from sequence data and without the use of templates is known as ab initio prediction.
It is frequently broken down into two independent sub-problems: the method of exploring the conformational space and the scoring system that can discriminate native or native-like structures from non-native ones. A reliable scoring system that can always direct a search towards the native fold doesn't exist yet, and there is no universal search strategy that can provide a sizeable sample of near-natives. Pathway models integrate the search and the scoring function.
According to Briefings in Bioinformatics in 2021, a program called TSSFinder was used to describe the promoter sequences from Eukaryotic species. The initial transcription start site (TSS) prediction approach that uses a probabilistic model based on linear chain conditional random fields (LCCRFs) is TSSFinder, which was originally disclosed in the literature. TSSFinder may be tailored to new organisms and is more accurate than previously released tools.
Geographical Penetration
North America accounted for around 37% of market share in 2022
Due to the rising need for gene prediction tool in healthcare, manufacturers in North America have chances of increasing their operations. There are many producers and suppliers in North America and owing to the quick economic growth of the region, industrial production has expanded, driving the demand for gene prediction tool.
Increasing expenditure on healthcare and rising research studies, advancement of technologies and different kinds of tool for research, and increase in biopharmaceutical or bioinformatics business establishment across the region are also contributing to the growth of gene prediction tool market share of this region. The market in this area is growing as people become more aware of various novel innovative tools. The aforementioned elements further attest to North America's hegemonic position in the world.
North America continues to be a key player in the global gene prediction tool market, with United States leading the way. Government initiatives promoting infrastructure development and investment, and a focus on rising advancements have fueled the demand for gene prediction tool in the U.S. United States have been proactive in executing several initiatives or researches, stimulating gene prediction tool demand.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global gene prediction tool market. As countries grappled with lockdowns, supply chain disruptions and reduced economic activity, the pharmaceutical sector, with a significant consumer of various device designs, was significantly impacted. Several efforts all throughout the world were impacted by the pandemic's broad lockdowns and limitations that started in early 2020.
Major medical and biotechnology industries came to a standstill and shifted their attention towards the management of COVID-19, leading to a slump in demand for gene prediction tool. Now several research studies have been initiated and companies have again started trial for their products efficiency. Overall, the impact of the pandemic on the global gene prediction tool market is expected to be relatively moderate, with the market continuing to grow steadily due to the ongoing need and research for iinovative tools, like ab-initio prediction tools.
Key Developments
• On June 1, 2023, the new PrimateAI-3D artificial intelligence (AI) algorithm, developed by Illumina Inc., an innovator in DNA sequencing as well as array-based technologies, predicts disease-causing genetic variants in patients with unparalleled accuracy. Two papers outlining the development of the algorithm and its implementation to fifty thousand genomes in the United Kingdom Biobank cohort were published in Science on June 2 (issue 6648) with the results.
• On January 23, 2023, By incorporating game-changing evaluation speed to assess and comprehend whole exome sequencing (WES), whole genome sequencing (WGS), and large panel sequencing data, the bioinformatics division of QIAGEN, QIAGEN Digital Insights, improved QIAGEN CLC Genomics Workbench Premium, which removes the data-analysis obstacles of next-generation sequencing (NGS).
• On May 16, 2022, A no-cost program for the annotation, characterisation, and visualization of specific antibodies will be made available by Geneious Biologics. The Geneious Biologics antibody annotation's potency can be personally experienced by researchers thanks to the online free antibody sequence analysis tool.
Competitive Landscape
The major global players in the market include Thermo Fisher Scientific Inc., Softberry, Inc., Illumina, Inc., QIAGEN, GenScript, DNASTAR, BGI,Geneious, Sangamo Therapeutics and Takara Bio Inc..
Why Purchase the Report?
• To visualize the global gene prediction tool market segmentation based on component, method, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of gene prediction tool market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global gene prediction tool market report would provide approximately 69 tables, 66 figures and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Component
3.2. Snippet by Method
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing collaborations and initiatives
4.1.1.2. Rising technological advancements and developments
4.1.2. Restraints
4.1.2.1. Limitations associated with the gene prediction tools
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. SWOT Analysis
5.6. Patent Analysis
5.7. Russia-Ukraine War Impact Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Component
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
7.1.2. Market Attractiveness Index, By Component
7.2. Software*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Services
7.3.1. Meglumine Antimoniate (Glucantim)
7.3.2. Similarity Based Searches
7.3.3. Ab-Initio Prediction
8. By Method
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
8.1.2. Market Attractiveness Index, By Method
8.2. Similarity Based Searches*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ab-Initio Prediction
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Drug Discovery *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Genetic Disorder Diagnosis
9.4. Biomedical Research
9.5. Others
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Biotechnology and Life Science Companies
10.4. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Thermo Fisher Scientific Inc.*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Softberry, Inc.
13.3. Illumina, Inc.
13.4. QIAGEN
13.5. GenScript
13.6. DNASTAR
13.7. BGI
13.8. Geneious
13.9. Sangamo Therapeutics
13.10. Takara Bio Inc.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Thermo Fisher Scientific Inc., 4. Key Developments, Softberry, Inc., Illumina, Inc., QIAGEN, GenScript, DNASTAR, BGI, Geneious, Sangamo Therapeutics, Takara Bio Inc.

표 목록 (Tables)

List of Tables

Table 1 Global Gene Prediction Tool Market Value, By Component, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Gene Prediction Tool Market Value, By Methods, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Gene Prediction Tool Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Gene Prediction Tool Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Gene Prediction Tool Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Gene Prediction Tool Market Value, By Component, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Gene Prediction Tool Market Value, By Component, 2021-2030 (US$ Million)

Table 8 Global Gene Prediction Tool Market Value, By Methods, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Gene Prediction Tool Market Value, By Methods, 2021-2030 (US$ Million)

Table 10 Global Gene Prediction Tool Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Gene Prediction Tool Market Value, By Application, 2021-2030 (US$ Million)

Table 12 Global Gene Prediction Tool Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Gene Prediction Tool Market Value, By End User, 2021-2030 (US$ Million)

Table 14 Global Gene Prediction Tool Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Gene Prediction Tool Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Gene Prediction Tool Market Value, By Component, 2021-2030 (US$ Million)

Table 17 North America Gene Prediction Tool Market Value, By Methods, 2021-2030 (US$ Million)

Table 18 North America Gene Prediction Tool Market Value, By Application, 2021-2030 (US$ Million)

Table 19 North America Gene Prediction Tool Market Value, By End User, 2021-2030 (US$ Million)

Table 20 North America Gene Prediction Tool Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Gene Prediction Tool Market Value, By Component, 2021-2030 (US$ Million)

Table 22 South America Gene Prediction Tool Market Value, By Methods, 2021-2030 (US$ Million)

Table 23 South America Gene Prediction Tool Market Value, By Application, 2021-2030 (US$ Million)

Table 24 South America Gene Prediction Tool Market Value, By End User, 2021-2030 (US$ Million)

Table 25 South America Gene Prediction Tool Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Gene Prediction Tool Market Value, By Component, 2021-2030 (US$ Million)

Table 27 Europe Gene Prediction Tool Market Value, By Methods, 2021-2030 (US$ Million)

Table 28 Europe Gene Prediction Tool Market Value, By Application, 2021-2030 (US$ Million)

Table 29 Europe Gene Prediction Tool Market Value, By End User, 2021-2030 (US$ Million)

Table 30 Europe Gene Prediction Tool Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Gene Prediction Tool Market Value, By Component, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Gene Prediction Tool Market Value, By Methods, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Gene Prediction Tool Market Value, By Application, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Gene Prediction Tool Market Value, By End User, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Gene Prediction Tool Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Gene Prediction Tool Market Value, By Component, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Gene Prediction Tool Market Value, By Methods, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Gene Prediction Tool Market Value, By Application, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Gene Prediction Tool Market Value, By End User, 2021-2030 (US$ Million)

Table 40 Thermo Fisher Scientific Inc.: Overview

Table 41 Thermo Fisher Scientific Inc.: Product Portfolio

Table 42 Thermo Fisher Scientific Inc.: Key Developments

Table 43 Softberry, Inc.: Overview

Table 44 Softberry, Inc.: Product Portfolio

Table 45 Softberry, Inc.: Key Developments

Table 46 Illumina, Inc.: Overview

Table 47 Illumina, Inc.: Product Portfolio

Table 48 Illumina, Inc.: Key Developments

Table 49 QIAGEN: Overview

Table 50 QIAGEN: Product Portfolio

Table 51 QIAGEN: Key Developments

Table 52 GenScript: Overview

Table 53 GenScript: Product Portfolio

Table 54 GenScript: Key Developments

Table 55 DNASTAR: Overview

Table 56 DNASTAR: Product Portfolio

Table 57 DNASTAR: Key Developments

Table 58 BGI: Overview

Table 59 BGI: Product Portfolio

Table 60 BGI: Key Developments

Table 61 Geneious: Overview

Table 62 Geneious: Product Portfolio

Table 63 Geneious: Key Developments

Table 64 Sangamo Therapeutics: Overview

Table 65 Sangamo Therapeutics: Product Portfolio

Table 66 Sangamo Therapeutics: Key Developments

Table 67 Takara Bio Inc.: Overview

Table 68 Takara Bio Inc.: Product Portfolio

Table 69 Takara Bio Inc.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 2 Global Gene Prediction Tool Market Share, By Component, 2022 & 2030 (%)

Figure 3 Global Gene Prediction Tool Market Share, By Methods, 2022 & 2030 (%)

Figure 4 Global Gene Prediction Tool Market Share, By Application, 2022 & 2030 (%)

Figure 5 Global Gene Prediction Tool Market Share, By End User, 2022 & 2030 (%)

Figure 6 Global Gene Prediction Tool Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Gene Prediction Tool Market Y-o-Y Growth, By Component, 2022-2030 (%)

Figure 8 Software Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 9 Services Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 10 Global Gene Prediction Tool Market Y-o-Y Growth, By Methods, 2022-2030 (%)

Figure 11 Similarity Based Searches Methods in Global Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 12 Ab-Initio Prediction Methods in Global Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 13 Global Gene Prediction Tool Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 14 Drug Discovery Application in Global Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 15 Genetic Disorder Diagnosis Application in Global Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 16 Biomedical Research Application in Global Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 17 Others Application in Global Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 18 Global Gene Prediction Tool Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 19 Hospitals End User in Global Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 20 Biotechnology and Life Science Companies End User in Global Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 21 Others End User in Global Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 22 Global Gene Prediction Tool Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 23 North America Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 24 Asia-Pacific Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 25 Europe Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 26 South America Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 27 Middle East and Africa Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 28 North America Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 29 North America Gene Prediction Tool Market Share, By Component, 2022 & 2030 (%)

Figure 30 North America Gene Prediction Tool Market Share, By Methods, 2022 & 2030 (%)

Figure 31 North America Gene Prediction Tool Market Share, By Application, 2022 & 2030 (%)

Figure 32 North America Gene Prediction Tool Market Share, By End User, 2022 & 2030 (%)

Figure 33 North America Gene Prediction Tool Market Share, By Country, 2022 & 2030 (%)

Figure 34 South America Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 35 South America Gene Prediction Tool Market Share, By Component, 2022 & 2030 (%)

Figure 36 South America Gene Prediction Tool Market Share, By Methods, 2022 & 2030 (%)

Figure 37 South America Gene Prediction Tool Market Share, By Application, 2022 & 2030 (%)

Figure 38 South America Gene Prediction Tool Market Share, By End User, 2022 & 2030 (%)

Figure 39 South America Gene Prediction Tool Market Share, By Country, 2022 & 2030 (%)

Figure 40 Europe Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 41 Europe Gene Prediction Tool Market Share, By Component, 2022 & 2030 (%)

Figure 42 Europe Gene Prediction Tool Market Share, By Methods, 2022 & 2030 (%)

Figure 43 Europe Gene Prediction Tool Market Share, By Application, 2022 & 2030 (%)

Figure 44 Europe Gene Prediction Tool Market Share, By End User, 2022 & 2030 (%)

Figure 45 Europe Gene Prediction Tool Market Share, By Country, 2022 & 2030 (%)

Figure 46 Asia-Pacific Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 47 Asia-Pacific Gene Prediction Tool Market Share, By Component, 2022 & 2030 (%)

Figure 48 Asia-Pacific Gene Prediction Tool Market Share, By Methods, 2022 & 2030 (%)

Figure 49 Asia-Pacific Gene Prediction Tool Market Share, By Application, 2022 & 2030 (%)

Figure 50 Asia-Pacific Gene Prediction Tool Market Share, By End User, 2022 & 2030 (%)

Figure 51 Asia-Pacific Gene Prediction Tool Market Share, By Country, 2022 & 2030 (%)

Figure 52 Middle East & Africa Gene Prediction Tool Market Value, 2021-2030 (US$ Million)

Figure 53 Middle East & Africa Gene Prediction Tool Market Share, By Component, 2022 & 2030 (%)

Figure 54 Middle East & Africa Gene Prediction Tool Market Share, By Methods, 2022 & 2030 (%)

Figure 55 Middle East & Africa Gene Prediction Tool Market Share, By Application, 2022 & 2030 (%)

Figure 56 Middle East & Africa Gene Prediction Tool Market Share, By End User, 2022 & 2030 (%)

Figure 57 Thermo Fisher Scientific Inc.: Financials

Figure 58 Softberry, Inc.: Financials

Figure 59 Illumina, Inc.: Financials

Figure 60 QIAGEN: Financials

Figure 61 GenScript: Financials

Figure 62 DNASTAR: Financials

Figure 63 BGI: Financials

Figure 64 Geneious: Financials

Figure 65 Sangamo Therapeutics: Financials

Figure 66 Takara Bio Inc.: Financials

글로벌 유전자 예측 도구 시장 – 2023-2030

Global Gene Prediction Tool Market -2023-2030